Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
European Journal of Medicinal Chemistry|October 30, 2025
Click-modifiable isatin hydrazones as COX-2, VEGFR-2, and carbonic anhydrase inhibitors: A multi-target approach to cancer therapyMaryam A Z El-Attar, Ola S Afifi, Azza Ismail, et al.
Acta Tropica|June 21, 2026
Oncostatin Level and Tumour Necrosis Factor-Alpha Gene Polymorphism in Predicting Blastocystis Infection in Inflammatory Bowel DiseaseAsmaa Ibrahim, Fatma Rageh, Shaymaa Abdelraheem Abdelhady, et al.
Emerging Infectious Diseases|August 21, 2020
Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015-March 2019Mokhtar R Gomaa, Amira S El Rifay, Dina Abu Zeid, et al.
BMC Infectious Diseases|August 18, 2023
Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortalityAmr Kandeel, Yassmin Moatasim, Manal Fahim, et al.
ACS Pharmacology & Translational Science|June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic DysfunctionPerihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
European Journal of Medicinal Chemistry|May 26, 2026
One destination, three routes: Tacrine-Celecoxib hybrids targeting cholinesterases, COX-2, and carbonic anhydrases in cognitive impairment linked to metabolic dysfunctionNayera W Hassan, Ola S Afifi, Maryam A Z El-Attar, et al.
Bulletin of the World Health Organization|January 30, 2025
A scoping review and expert consensus on digital determinants of healthRobin van Kessel, Laure-Elise Seghers, Michael Anderson, et al.
Pageof 20